Trials / Terminated
TerminatedNCT00229151
Sleep Deprivation and Advancement of Sleep Period as Treatment for Bipolar Depression.
Sleep Deprivation and Three Days Sleep Phase Advancement as Treatment for Bipolar Depression.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 5 (actual)
- Sponsor
- Norwegian University of Science and Technology · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if sleep deprivation and sleep phase advancement is effective treatment of bipolar patients in a depressive phase.
Detailed description
Background: The onset of therapeutic action for most anti-depressive treatments is usually two weeks. During this period patients suffer from great symptomatic distress. Treatment options that are effective in this period is therefore of interest for psychiatric wards. Aim: To explore if sleep deprivation and three days sleep phase advancement is effective treatment for inpatients with bipolar disorder in a depressive phase. Method: A randomized controlled trial with 24 patients diagnosed with bipolar disorder. Patients will be randomized to treatment as usual in an psychiatric ward, or sleep deprivation and three days sleep phase advancement. Patients in the treatment as usual group will be offered treatment with sleep deprivation and sleep phase advancement after five weeks if they still meet inclusion criteria.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Sleep deprivation and sleep phase advancement | Total sleep deprivation from 0800 to 1700 next day, and three day sleep phase advancement following sleep deprivation. |
| OTHER | usual treatment | Treatment as usual in the psychiatric ward. Patients in this group will be offered treatment with sleep deprivation and sleep phase advancement after five weeks if they still meet inclusion criteria |
Timeline
- Start date
- 2005-10-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2005-09-29
- Last updated
- 2012-04-09
Locations
1 site across 1 country: Norway
Source: ClinicalTrials.gov record NCT00229151. Inclusion in this directory is not an endorsement.